A Phase I/II Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant Melanoma
Condition: Malignant Melanoma Interventions: Genetic: delolimogene mupadenorepvec; Biological: atezolizumab Sponsors: Lokon Pharma AB; Precision Oncology LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials